Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway

Experimental Cell Research

Volumn 323, Issue 2, 2014, Pages 352-358

  Zhan, Jun Kun ^a   Wang, Yan Jiao ^a   Wang, Yi ^a   Tang, Zhi Yong ^a   Tan, Pan ^a   Huang, Wu ^a   Liu, You Shuo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adiponectin; AMPK mTOR; Osteoblastic differentiation; Vascular smooth muscle cells

Indexed keywords

ADIPONECTIN; ALIZARIN RED S; GLYCEROL 2 PHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; S6 KINASE; TRANSCRIPTION FACTOR RUNX2; TUBERIN;

ARTICLE; BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL PATHWAY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OSTEOBLAST; OSTEOBLASTIC DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; STAINING; TISSUE DIFFERENTIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADIPONECTIN; AMPK/MTOR; OSTEOBLASTIC DIFFERENTIATION; VASCULAR SMOOTH MUSCLE CELLS;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GLYCEROPHOSPHATES; HUMANS; OSTEOBLASTS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84897499323     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.02.016     Document Type: Article

References (34)

1. Nakano-Kurimoto R., Ikeda K., Uraoka M., Nakagawa Y., Yutaka K., Koide M., et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:1673-1684.
2. Abedin M., Tintut Y., Demer L.L. Vasacular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1161-1170.
3. Liu Y.S., Lu Y., Liu W., Xie H., Luo X.H., Wu X.P., et al. Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts. Amino Acids 2010, 38:763-769.
4. Ciceri P., Volpi E., Brenna I., Arnaboldi L., Neri L., Brancaccio D., et al. Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Nephrol. Dial. Transplant. 2012, 27:122-127.
5. Steitz S.A., Speer M.Y., Curinga G., Yang H.Y., Haynes P., Aebersold R., et al. Smooth muscle cell phenotypic transition associated with calcification upregulation of cbfα1 and downregulation of smooth muscle lineage markers. Circ. Res. 2001, 89:1147-1154.
6. Takahashi M., Arita Y., Yamagata K. Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. 2000, 24:861-868.
7. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 1996, 221:286-289.
8. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26:439-451.
9. Han S.H., Sakuma I., Shin E.K., Koh K.K. Antiatherosclerotic and antiinsulin resistance effects of adiponectin: basic and clinical studies. Prog. Cardiovasc. Dis. 2009, 52:126-140.
10. Barb D., Neuwirth A., Mantzoros C.S., Balk S.P. Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr. Relat. Cancer 2007, 14:995-1005.
11. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 2004, 94:e27-e31.
12. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res. 2005, 309:99-109.
13. Su Y.X., Deng H.C., Zhang M.X., Long J., Peng Z.G. Adiponectin inhibits PDGF-induced mesangial cell proliferation: regulation of mammalian target of rapamycin-mediated survival pathway by adenosine 5-monophosphate-activated protein kinase. Horm. Metab. Res. 2012, 44:21-27.
14. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011, 25:1895-1908.
15. Rutter G.A., Da Silva Xavier G., Leclerc I. Roles of 5[U+05F3]-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 2003, 375:1-16.
16. Corton J.M., Gillespie J.G., Hawley S.A., Hardie D.G. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur. J. Biochem. 1995, 229:558-565.
17. Chiang P.C., Lin S.C., Pan S.L., Kuo C.H., Tsai I.L., Kuo M.T., et al. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. Biochem. Pharmacol. 2010, 79:162-171.
18. Han D., Li S.J., Zhu Y.T., Liu L., Li M.X. LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer. Asian Pac. J. Cancer Prev. 2013, 14:4033-4039.
19. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 2002, 10:457-468.
20. Zhan J., Wang Y., Wang Y., Wang S., Tan P., Huang W., et al. The mTOR signaling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells. Can. J. Cardiol. 2013, 10.1016/j.cjca.2013.11.005.
21. Luo X.H., Zhao L.L., Yuan L.Q., Wang M., Xie H., Liao E.Y. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J. Bone Miner. Res. 2009, 24:1461-1468.
22. Komori T. Requisite roles of Runx2 and Cbfb in skeletal development. J. Bone Miner. Metab. 2003, 21:193-197.
23. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. 2009, 196:65-80.
24. Zavaczki E., Jeney V., Agarwal A., Zarjou A., Oros M., Katkó M., et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 2011, 80:731-739.
25. Giachelli C.M., Speer M.Y., Li X., Rajachar R.M., Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ. Res. 2005, 96:717-722.
26. Maahs D.M., Ogden L.G., Kinney G.L., Wadwa P., Snell-Bergeon J.K., Dabelea D., et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005, 111:747-753.
27. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 2004, 10:1384-1389.
28. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
29. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
30. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:77-590.
31. 2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 2004, 279:15719-15722.
32. Peterson R.T., Beal P.A., Comb M.J., Schreiber S.L. FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 2000, 275:7416-7423.
33. Harrington L.S., Findlay G.M., Gray A., Tolkacheva T., Wigfield S., Rebholz H., et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. Cell Biol. 2004, 166:213-223.
34. Magnuson B., Ekim B., Fingar D.C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem. J. 2012, 441:1-21.